Phase 1 Study Evaluating the Association of the Cyclin-Dependent Kinase 4/6 Inhibitor Ribociclib and Cetuximab in Recurrent/Metastatic p16-Negative Squamous Cell Carcinoma of the Head and Neck-Reference-Cited by-同舟云学术

Phase 1 Study Evaluating the Association of the Cyclin-Dependent Kinase 4/6 Inhibitor Ribociclib and Cetuximab in Recurrent/Metastatic p16-Negative Squamous Cell Carcinoma of the Head and Neck

Published:2019-03-19 Issue: Volume:9 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Seront Emmanuel,Schmitz Sandra,Papier Matthias,van Maanen Aline,Henry Stéphanie,Lonchay Christophe,Rottey Sylvie,van Caloen Gabrielle,Machiels Jean-Pascal

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference22 articles.

1. Cancer statistics, 2016;Siegel;CA Cancer J Clin.,2016

2. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients;Pignon;Radiother Oncol.,2009

3. Tumor epidermal growth factor receptor and EGFR PY1068 are independent prognostic indicators for head and neck squamous cell carcinoma;Wheeler;Clin Cancer Res.,2012

4. Epidermal growth factor receptor expression in pretreatment biopsies from head and neck squamous cell carcinoma as a predictive factor for a benefit from accelerated radiation therapy in a randomized controlled trial;Bentzen;J Clin Oncol.,2005

5. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck;Bonner;N Engl J Med.,2006

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the Therapeutic Implications of Co-Targeting the EGFR and Spindle Assembly Checkpoint Pathways in Oral Cancer;Pharmaceutics;2024-09-11

2. A systematic review of contemporary phase I trials in patients with recurrent/metastatic head and neck cancer;Oral Oncology Reports;2024-09

3. Combination Therapy as a Promising Way to Fight Oral Cancer;Pharmaceutics;2023-06-04

4. CDK4/6 and autophagy inhibitors synergize to suppress the growth of human head and neck squamous cell carcinomas;Molecular Carcinogenesis;2023-05-03

5. DNA Damage Response Mechanisms in Head and Neck Cancer: Significant Implications for Therapy and Survival;International Journal of Molecular Sciences;2023-02-01